company into three independent, publicly traded companies through tax-free spin-offs giving investors a choice of retaining
or selling their shares in the agricultural, material science, and specialty products businesses. Each of the three businesses
will have Advisory Committees. The breakup is expected to occur 18 to 24 months following closing. DowDuPont will
have dual headquarters in Midland, Michigan and Wilmington Delaware.
The deal will require regulatory approval in several countries and is expected to face intense antitrust scrutiny due to its
huge size and scale. Groups representing various farm and agricultural interests have expressed concerns about the merger
harming competition, particularly in seeds and crop chemicals markets resulting in higher prices for these products. To get
approval, the firms may have to divest significant businesses in areas where the merger is expected to limit competition.
This could reduce the realization of anticipated synergies and the growth potential of some of the businesses to be spun off.
If approved by the regulators, postclosing implementation will be enormously challenging. Within two years following
closing, DowDuPont is expected to realize cost synergies annually totaling $3 billion in expenses. During the same
timeframe, the new firm must undergo extensive reorganization in order to create the proposed new subsidiaries that are to
be spun off to shareholders. Given the probable interrelationships between and among the various operations, this is likely
to prove to be a gargantuan task.
Reorganization involves moving people around, trimming overhead, allocating debt, renegotiating customer and supply
agreements, disentangling jointly used information technology systems, and ensuring that the eventual spun off units will
be considered tax free to shareholders. The logistics of such activities often take many months and DowDuPont is
expecting to implement three spin offs in a relatively short period of time. DuPont’s last spinoff, Chemours, a performance
chemicals unit, has been a disaster, losing three-quarters of its value in less than a year after its separation and represents
the ills that can befall a spinoff.
With a total workforce exceeding 100,000 people, the major task confronting the new firm will be in retaining and
keeping motivated talented people. While it is customary to use retention bonuses to keep those workers that will be needed
during the transition period leading up to the spinoffs, the resulting uncertainty, stress, anger, frustration, and confusion are
likely to result in significant attrition. While such attrition may be desired from a cost savings standpoint, some of those
employees leaving will be critical for the ongoing operations of the business. In businesses that have been as integrated as
Dow and DuPont, layers of management will be stripped away. Management turnover typically tends to be substantially
higher during this period leading to confusion among reporting relationships and disjointed communication. Also, it is
likely that management talent will be stretched thin as managers are asked to maintain or improve the performance of their
business units and to simultaneously implement the logistics required for the planned spinoffs.
Tax considerations are a primary driver of the deal. The tax-free treatment of the spin-offs is viewed as a highly tax
efficient alternative to selling selected businesses which could result in significant taxable gains to Dow and DuPont.
Structured as a merger of equals in a share for share exchange, the DowDuPont deal also is tax free to shareholders.
Typically, companies that have been through a change of control are liable to pay capital gains taxes on subsequent spin–
offs, under section 355 of the U.S. Internal Revenue Code (see Chapter 16 for more detail). If both companies, however, do
not formally undergo a change of control, the spin-offs can be tax-free. After their merger, Dow and DuPont plan to argue
that no change of control will have occurred by structuring their initial deal as a merger of equals. Bolstering their view that
a change of control has not occurred is that the two companies have many shareholders in common. Vanguard Group Inc.,
State Street Global Advisors, Capital World Investors and BlackRock Inc. are, in that order, the top holders of both
companies’ stock.1
Investors immediately expressed skepticism following the deal’s announcement on December 11, 2015 with Dow’s
share price falling by 2.8% to $53.57 and DuPont’s shares falling by 5.6% to $72.91. DuPont’s shares fell more
precipitously on news that its 2016 sales growth would be flat. The firm also announced plans to cut its global workforce by
10% as part of its restructuring program. Investors expressed concern about the deal’s complexity, the potential for the
deal not to close due to regulatory issues, and the potential difficulty in implementing the breakup of the company in the
time frame indicated by management.
Discussion Questions and Answers:
1The most recent precedent in which a merger of equals’ structure was employed to argue successfully that a change in
control had not taken place (and therefore there was not any actual sale) was in the 2007 merger of drug distributors
AmerisourceBergen Corp and Kindred Healthcare Inc. Once the merger took place the new company spun off its pharmacy
businesses tax free to shareholders.